乙酰肝素酶促凝结构域在出血与伤口愈合中的作用
研究生成24种乙酰肝素酶衍生肽,以Xa因子生成实验筛选出促凝效果最好的肽14和肽16,并在出血小鼠模型和伤口愈合小鼠模型中评估。肽14和肽16使Xa因子水平升高两至三倍,高水平时引起消耗性凝血病,局部或皮下给药使出血模型凝血时间缩短50%,伤口愈合模型伤口血管增多、面积缩小至对照的五分之一。
要点
- 肽14和肽16使Xa因子水平升高两至三倍,高水平时引起消耗性凝血病。
- 出血模型中局部或皮下给予肽14或肽16,凝血形成时间缩短50%。
- 伤口愈合模型中给药1周,伤口血管增多、面积缩小至对照的五分之一。
核心结论
- 研究确定了乙酰肝素酶 putative 促凝结构域,该结构域衍生肽显著缩短出血时间并增强伤口愈合。
研究设计与样本
- 研究生成24种乙酰肝素酶衍生肽,在Xa因子生成实验中评估其效果。
- 将促凝效果最好的肽14和肽16用于出血小鼠模型和伤口愈合小鼠模型研究。
主要发现
- 肽14和肽16使Xa因子水平升高两至三倍,高水平时引起消耗性凝血病。
- 既往研究的TFPI-2衍生肽可抑制肽14和肽16诱导的促凝效应。
- 出血模型中局部或皮下给予肽14或肽16,凝血形成时间缩短50%。
- 伤口愈合模型中局部或皮下给予肽14或肽16 1周,伤口血管增多、面积缩小至对照的五分之一。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Heparanase forms a complex with tissue factor and enhances the generation of factor Xa. The present study was aimed to identify the procoagulant domain of heparanase. Procoagulant peptides significantly shortened bleeding time and enhanced wound healing. Tissue factor pathway inhibitor (TFPI)-2 derived peptides inhibited the procoagulant peptides. SUMMARY: Background Heparanase, which is known to be involved in angiogenesis and metastasis, was shown to form a complex with tissue factor (TF) and to enhance the generation of activated factor X (FXa). Our study demonstrated that peptides derived from TF pathway inhibitor (TFPI)-2 impeded the procoagulant effect of heparanase, and attenuated inflammation, tumor growth, and vascularization. Aims To identify the procoagulant domain in the heparanase molecule, and to evaluate its effects in a model of wound healing that involves inflammation and angiogenesis. Methods Twenty-four potential peptides derived from heparanase were generated, and their effect was studied in an assay of FXa generation. Peptides 14 and 16, which showed the best procoagulant effect, were studied in a bleeding mouse model and in a wound-healing mouse model. Results Peptides 14 and 16 increased FXa levels by two-fold to three-fold, and, at high levels, caused consumption coagulopathy. The TFPI-2-derived peptides explored in our previous study were found to inhibit the procoagulant effect induced by peptides 14 and 16. In the bleeding model, time to clot formation was shortened by 50% when peptide 14 or peptide 16 was topically applied or injected subcutaneously. In the wound-healing model, the wound became more vascular, and its size was reduced to one-fifth as compared with controls, upon 1 week of exposure to peptide 14 or peptide 16 applied topically or injected subcutaneously. Conclusions The putative heparanase procoagulant domain was identified. Peptides derived from this domain significantly shortened bleeding time and enhanced wound healing.
引用
- Crispel Y, Ghanem S, Attias J, et al. Involvement of the heparanase procoagulant domain in bleeding and wound healing. J Thromb Haemost. 2017. PMID: 28439967. doi:10.1111/jth.13707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。